Regulatory and market issues are driving change within healthcare & life science organizations. Regulatory requirements such as Meaningful Use and Affordable Care Act in the US are driving a fundamental shift away from the volume-based, fee-for-service model that has dominated the healthcare industry for decades, to a more performance-based, outcomes-driven approach. Payer organizations are mandating more cost-effective care and growing competition is putting pressure on organizations to increase referrals, revenues and profitability. Perhaps most significantly consumer advocacy groups and individual consumers are demanding better consumer safety, access and value, as well as higher-quality. Life science organizations, specifically Pharma are also subject to change with the looming patent cliffs and regulatory pressures (Read more here). These changes are dramatically re-shaping the industry to form a patient centric healthcare ecosystem where healthcare & life science organizations must collaborate and integrate to drive optimum cost effective outcomes sustainably (Patient centric ecosystem) . Organizations across the ecosystem are forced to reconsider their business models, restructure their operations, and redefine what value and success mean for themselves, their consumers and the many stakeholders of these rapidly changing industries.
Read more at the site and contribute your opinion to the IBM global survey here https://www-304.ibm.com/connections/blogs/ibm_healthcare/entry/what_is_the_role_of_analytics_across_the_integrated_healthcare_life_sciences_ecosystem5?lang=en_us